MoonLake Immunotherapeutics - CLASS A ORD (MLTX)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / CLASS A ORD
Number of holders
43
Total Shares
39.4M
Shares change
+1.67M
Total reported value, excl. options
$843M
Value change
+$59.2M
Put/Call ratio
0
Number of buys
31
Number of sells
-17
Price
$21.39
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.